Products
Our products
Learn more about our product portfolio and how we’re prioritising vaccines and specialty medicines to get ahead of disease together.
Scroll to explore
Our vaccines and medicines
Getting ahead means preventing disease as well as treating it. Our R&D focus is to deliver new vaccines and medicines using the science of the immune system, human genetics and advanced technologies.
12
vaccines manufacturing sites - enabling a supply capability to produce and deliver 500 million vaccine doses in 2022
1.5m
doses of vaccines delivered every day
20+
vaccines, helping to protect lives from diseases including meningitis, shingles, flu, whooping cough, measles, hepatitis and human papillomavirus (HPV)
40%
of the world’s children receive a GSK vaccine each year
2.3bn
packs of medicines and doses of vaccines delivered in 2022
Explore our innovation stories
Innovation is at the very core of GSK. Discover how we’re uniting science, technology and talent to get ahead of disease together.
‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine development
‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics
Scientists gain ground in centuries-long malaria struggle – but more innovation is needed to stay ahead of evolving parasites
Modern technologies are doubling the odds of scientists making life-changing medical discoveries
Age-related decline in immunity: why does it matter and what can be done about it?
Vaccinations are not just for children: why adult immunisation is a health and economic necessity
